TCL Archive Niederhuber: Clinical Trials System Must Refocus To Emphasize Translational Studies. July 9, 2010
TCL Archive The NCI director and acting FDA commissioner called for faster approval of cancer drugs in speech to FDA staff. October 21, 2005
TCL Archive In Brief: HSAs Would Delay NCI Awards By Nine Months; Mary Lasker Names to Carter Health Group September 17, 1976
TCL Archive New Drug Approvals Point To Greater Role Of Randomization In Cancer Clinical Trials. European Standards Will Demand More Rigor. February 24, 2006
